Conclusions/interpretation These results show that the previously demonstrated beneficial effects of these agents on complication-causing pathways in rodent models of diabetic complications also occur in humans with type 1 diabetes.
Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes.
Du X, Edelstein D, Brownlee M.
Diabetologia. 2008 Oct;51(10):1930-2. Epub 2008 Jul 29.
PMID: 18663426
DOI: 10.1007/s00125-008-1100-2